These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

865 related items for PubMed ID: 19432961

  • 1. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.
    Lowery AJ, Miller N, Devaney A, McNeill RE, Davoren PA, Lemetre C, Benes V, Schmidt S, Blake J, Ball G, Kerin MJ.
    Breast Cancer Res; 2009; 11(3):R27. PubMed ID: 19432961
    [Abstract] [Full Text] [Related]

  • 2. Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.
    McDermott AM, Miller N, Wall D, Martyn LM, Ball G, Sweeney KJ, Kerin MJ.
    PLoS One; 2014; 9(1):e87032. PubMed ID: 24498016
    [Abstract] [Full Text] [Related]

  • 3. Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas.
    Fernandes RC, Bevilacqua JL, Soares IC, Siqueira SA, Pires L, Hegg R, Carvalho FM.
    Histopathology; 2009 Sep; 55(3):346-52. PubMed ID: 19723150
    [Abstract] [Full Text] [Related]

  • 4. Correlation of miRNA expression profiling in surgical pathology materials, with Ki-67, HER2, ER and PR in breast cancer patients.
    Sakurai M, Masuda M, Miki Y, Hirakawa H, Suzuki T, Sasano H.
    Int J Biol Markers; 2015 May 26; 30(2):e190-9. PubMed ID: 25907662
    [Abstract] [Full Text] [Related]

  • 5. Ductal invasive mammary carcinoma--clinicopathological prognostic factors related to immunohistochemical expression of hormonal receptors and Her2/neu oncoprotein.
    Recăreanu F, Simionescu C, Georgescu CV, Pirici E.
    Rom J Morphol Embryol; 2011 May 26; 52(3 Suppl):1059-64. PubMed ID: 22119825
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hormonal Receptor, Human Epidermal Growth Factor and Its Association with Breast Cancer Tumor Characteristics in Albania.
    Pajenga E, Rexha T, Çeliku S, Ugrinska A, Bejtja G.
    Cent Eur J Public Health; 2016 Sep 26; 24(3):171-175. PubMed ID: 27760283
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical Expression of BRCA1 Protein, ER, PR and Her2/neu in Breast Cancer: A Clinicopathological Study.
    Hussein IA, Ahmed ST, Hameedi AD, Naji RZ, Alharbawi L, Alkhaytt M, Pity IS.
    Asian Pac J Cancer Prev; 2020 Apr 01; 21(4):1025-1029. PubMed ID: 32334465
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hormone receptors do not predict the HER2/neu status in all age groups of women with an operable breast cancer.
    Huang HJ, Neven P, Drijkoningen M, Paridaens R, Wildiers H, Van Limbergen E, Berteloot P, Amant F, Vergote I, Christiaens MR.
    Ann Oncol; 2005 Nov 01; 16(11):1755-61. PubMed ID: 16085689
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunohistochemical Expression Of Matrix Metalloproteinase-1 (MMP-1) in Different Types Of Breast Carcinoma And Its Comparison With ER/PER and HER2/neu.
    Shamsi FB, Anwar A, Lail RA, Bukhari MH, Naseem N, Nagi AH.
    J Ayub Med Coll Abbottabad; 2022 Nov 01; 34(1):12-16. PubMed ID: 35466619
    [Abstract] [Full Text] [Related]

  • 15. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY, Kim S, Lee JH, Lee HC, Lee SK, Kil WH, Kim SW, Lee JE, Nam SJ.
    BMC Cancer; 2015 Mar 18; 15():138. PubMed ID: 25880075
    [Abstract] [Full Text] [Related]

  • 16. Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours-a review.
    Yeung C, Hilton J, Clemons M, Mazzarello S, Hutton B, Haggar F, Addison CL, Kuchuk I, Zhu X, Gelmon K, Arnaout A.
    Cancer Metastasis Rev; 2016 Sep 18; 35(3):427-37. PubMed ID: 27405651
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical characterization of molecular subtypes of invasive breast cancer: a study from North India.
    Verma S, Bal A, Joshi K, Arora S, Singh G.
    APMIS; 2012 Dec 18; 120(12):1008-19. PubMed ID: 23030684
    [Abstract] [Full Text] [Related]

  • 18. Pattern of hormone receptors and human epidermal growth factor receptor 2 status in sub-Saharan breast cancer cases: Private practice experience.
    Nwafor CC, Keshinro SO.
    Niger J Clin Pract; 2015 Dec 18; 18(4):553-8. PubMed ID: 25966732
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of Estrogen Receptor- and Progesterone Receptor-Regulating MicroRNAs in Breast Cancer.
    Kalinina T, Kononchuk V, Alekseenok E, Obukhova D, Sidorov S, Strunkin D, Gulyaeva L.
    Genes (Basel); 2021 Apr 16; 12(4):. PubMed ID: 33923732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.